CAMPHOR, MENTHOL

N/A

Manufactured by Chattem, Inc.

1,597 FDA adverse event reports analyzed

Last updated: 2026-04-15

About CAMPHOR, MENTHOL

CAMPHOR, MENTHOL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Chattem, Inc.. The most commonly reported adverse reactions for CAMPHOR, MENTHOL include DRUG INEFFECTIVE, NO ADVERSE EVENT, APPLICATION SITE BURN, PAIN, APPLICATION SITE PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CAMPHOR, MENTHOL.

Top Adverse Reactions

DRUG INEFFECTIVE221 reports
NO ADVERSE EVENT160 reports
APPLICATION SITE BURN57 reports
PAIN47 reports
APPLICATION SITE PAIN37 reports
BURNING SENSATION32 reports
BLISTER30 reports
SKIN BURNING SENSATION27 reports
PAIN IN EXTREMITY25 reports
DIARRHOEA24 reports
APPLICATION SITE ERYTHEMA23 reports
ARTHRALGIA23 reports
APPLICATION SITE VESICLES22 reports
FATIGUE22 reports
NAUSEA22 reports
THERMAL BURN22 reports
ERYTHEMA21 reports
HEADACHE21 reports
DIZZINESS20 reports
BACK PAIN19 reports
BURNS SECOND DEGREE19 reports
CHEMICAL INJURY18 reports
DYSPNOEA18 reports
VOMITING18 reports
PRURITUS17 reports
CONSTIPATION16 reports
HYPERSENSITIVITY16 reports
FALL15 reports
OFF LABEL USE15 reports
SKIN EXFOLIATION15 reports
INSOMNIA14 reports
URINARY TRACT INFECTION14 reports
CHEMICAL BURN13 reports
PERIPHERAL SWELLING13 reports
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE13 reports
PRODUCT QUALITY ISSUE13 reports
RASH13 reports
GAIT DISTURBANCE12 reports
MALAISE12 reports
PRODUCT DOSE OMISSION ISSUE12 reports
PRODUCT USE ISSUE12 reports
SCAR12 reports
NECK PAIN11 reports
INFUSION SITE PAIN10 reports
MUSCLE SPASMS10 reports
MYALGIA10 reports
PNEUMONIA10 reports
SKIN DISCOLOURATION10 reports
ABDOMINAL PAIN9 reports
BURNS THIRD DEGREE9 reports
DECREASED APPETITE9 reports
FEELING ABNORMAL9 reports
HYPOAESTHESIA9 reports
LOSS OF CONSCIOUSNESS9 reports
SOMNOLENCE9 reports
ASTHENIA8 reports
CONDITION AGGRAVATED8 reports
INFECTION8 reports
MUSCULOSKELETAL STIFFNESS8 reports
SCAB8 reports
COUGH7 reports
DEATH7 reports
EXPIRED PRODUCT ADMINISTERED7 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION7 reports
MOBILITY DECREASED7 reports
MUSCULOSKELETAL PAIN7 reports
NASAL CONGESTION7 reports
PRODUCT ADHESION ISSUE7 reports
PYREXIA7 reports
SWELLING7 reports
URTICARIA7 reports
WEIGHT DECREASED7 reports
WEIGHT INCREASED7 reports
ABDOMINAL DISCOMFORT6 reports
ALOPECIA6 reports
ANXIETY6 reports
COVID 196 reports
DEPRESSION6 reports
DRUG EFFECTIVE FOR UNAPPROVED INDICATION6 reports
FEELING HOT6 reports
INFUSION SITE ERYTHEMA6 reports
NASOPHARYNGITIS6 reports
PRODUCT USE IN UNAPPROVED INDICATION6 reports
SKIN IRRITATION6 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS6 reports
APPLICATION SITE DISCOLOURATION5 reports
ARTHRITIS5 reports
BLOOD PRESSURE DECREASED5 reports
BRONCHITIS5 reports
CHEST PAIN5 reports
CONTUSION5 reports
DISCOMFORT5 reports
DRUG EFFECT LESS THAN EXPECTED5 reports
HYPERAESTHESIA5 reports
HYPOTENSION5 reports
JOINT SWELLING5 reports
LIMB DISCOMFORT5 reports
MEMORY IMPAIRMENT5 reports
MYOCARDIAL INFARCTION5 reports
OEDEMA PERIPHERAL5 reports

Report Outcomes

Out of 814 classified reports for CAMPHOR, MENTHOL:

Serious 37.3%Non-Serious 62.7%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female417 (68.0%)
Male188 (30.7%)
Unknown8 (1.3%)

Reports by Age

Age 5915 reports
Age 6013 reports
Age 5210 reports
Age 6310 reports
Age 449 reports
Age 649 reports
Age 328 reports
Age 518 reports
Age 578 reports
Age 698 reports
Age 457 reports
Age 667 reports
Age 687 reports
Age 276 reports
Age 356 reports
Age 466 reports
Age 716 reports
Age 766 reports
Age 796 reports
Age 395 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CAMPHOR, MENTHOL?

This profile reflects 1,597 FDA FAERS reports that mention CAMPHOR, MENTHOL. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CAMPHOR, MENTHOL?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, NO ADVERSE EVENT, APPLICATION SITE BURN, PAIN, APPLICATION SITE PAIN, BURNING SENSATION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CAMPHOR, MENTHOL?

Labeling and FAERS entries often list Chattem, Inc. in connection with CAMPHOR, MENTHOL. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.